		<rss version="2.0">
		<channel>
		<title>Adderall News RSS Feed - Lawyer Seek Litigation</title>
		<link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link>
		<description>What is Adderall? 
Adderall and Adderall XR are prescription drugs manufactured by Shire Pharmaceuticals that are used in the treatment of Attention Deficit Hyperactivity Disorder, a condition more commonly known as ADHD. Traditionally, ADHD was diagnosed only in children; however, the number of adults diagnosed with ADHD has increased significantly over the past few years. Presently, Adderall is prescribed to both adults and children over the age of 6 who suffer from ADHD. Adderall, which contains a combination of the stimulants amphetamine and dextroamphetamine, is designed to stimulate the central nervous system. ... </description>
		<language>en-us</language>
		
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature.</description>			
			</item>			
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature</description>			
			</item>			
					<item>
			<title>F.D.A. Strengthens Warnings on Stimulants</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link><description>The warnings on stimulants like Ritalin caution against their use in adults or children with heart problems.</description>			
			</item>			
					<item>
			<title>New warnings on ADHD drugs</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link><description> Several drugs to treat attention deficit hyperactivity disorder must include new warning information about the risk of heart problems and psychotic behavior, U.S. health officials said on Monday.</description>			
			</item>			
					<item>
			<title>Avoid ADHD drugs, Canada tells heart patients</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link><description> Canada&#39;s health ministry on Friday warned people with high blood pressure, heart disease and a number of other medical ailments not to take drugs used to manage Attention Deficit Hyperactivity Disord...</description>			
			</item>			
					<item>
			<title>Study: ADHD Drugs Send Thousands to ERs</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link><description>-- Accidental overdoses and side effects from attention deficit drugs likely send thousands of children and adults to emergency rooms, according to the first national estimates of the problem.    </description>			
			</item>			
					<item>
			<title>FDA Panel Calls for Strongest Warning on ADHD Drugs</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link><description> THURSDAY, Feb. 9 (HealthDay News) -- A U.S. advisory panel recommended on Thursday the strongest possible label warning for Ritalin and other stimulants used to treat attention-deficit hyperactivity ...</description>			
			</item>			
					<item>
			<title>Feds Consider Warnings on ADHD Drugs</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link><description> A federal health official said Thursday that there was a strong possibility that popular drugs like Ritalin used to treat attention deficit hyperactivity disorder may be linked to the deaths of 25 pe...</description>			
			</item>			
					<item>
			<title>US reports deaths of attention drug patients</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link><description> U.S. regulators were told of 24 deaths among patients who took Shire Pharmaceuticals Group Plc&#39;s attention deficit drug Adderall through 2003, according to a report released on Wednesday.</description>			
			</item>			
					<item>
			<title>Attention-Deficit Drugs Need Watching, U.S. FDA Says (Update1)</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Adderall-P16/News/</link><description>Feb. 8 (Bloomberg) -- Shire Plc&#39;s Adderall and other stimulants used to treat attention-deficit disorder should be tracked for the risk of sudden death and heart problems, U.S. drug regulators said in...</description>			
			</item>			
				
		</channel>
		</rss> 
		